tradingkey.logo
tradingkey.logo
Search

Nasus Pharma Ltd

NSRX
Add to Watchlist
3.030USD
+0.020+0.63%
Close 07-31 16:00ETQuotes delayed by 15 min
35.48MMarket Cap
LossP/E TTM

NSRX Financials

See Nasus Pharma Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Nasus Pharma Ltd Earnings Date

Latest Release
Mar 25, 2026
EPS / Forecast
--/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.73
-332.33%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q4
FY2025Q2
FY2024Q4
Financial Indicators
Debt to assets ratio
----
----
--0.00%
Current assets
962.36%4.86M
--291.00K
--457.00
Total current liabilities
-44.95%2.16M
--4.95M
--3.93K
Total assets
597.91%5.00M
--639.00K
--717.00
Total liabilities
-43.09%2.24M
--4.95M
--3.93K
Total equity
186.18%2.77M
---4.31M
---3.21K

FAQs

What are the current assets of Nasus Pharma Ltd?

According to Nasus Pharma Ltd's FY2025 earnings report, its current assets were 4.86M, with a year-on-year change of 962.36.

What are the total assets of Nasus Pharma Ltd?

According to Nasus Pharma Ltd's FY2025 earnings report, its total assets of Nasus Pharma Ltd were 5.00M, with a year-on-year change of 597.91.

What are the total liabilities of Nasus Pharma Ltd?

According to Nasus Pharma Ltd's FY2025 earnings report, its total liabilities of Nasus Pharma Ltd were 2.24M, with a year-on-year change of -43.09.

What is the total equity of Nasus Pharma Ltd?

According to Nasus Pharma Ltd's FY2025 earnings report, its total equity of Nasus Pharma Ltd was 2.77M, with a year-on-year change of 186.18.

What is the net operating income of Nasus Pharma Ltd?

According to Nasus Pharma Ltd's FY2025 earnings report, its net operating income of Nasus Pharma Ltd was -4.90M, with a year-on-year change of -354.92.

What is the net financing of Nasus Pharma Ltd?

According to Nasus Pharma Ltd's FY2025 earnings report, its net financing of Nasus Pharma Ltd was 8.92M, with a year-on-year change of 1058.44.

What is the Earnings Per Share (EPS) of Nasus Pharma Ltd?

According to Nasus Pharma Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -0.73, with a year-on-year change of -332.33.

What is the net income of Nasus Pharma Ltd?

According to Nasus Pharma Ltd's FY2025 earnings report, its net income was -5.86M, with a year-on-year change of -282.25.

What is the Return on Assets (ROA) of Nasus Pharma Ltd?

According to Nasus Pharma Ltd's FY2025 earnings report, its Return on Assets (ROA) was -202.94, with a year-on-year change of 24.09.

What is the operating profit of Nasus Pharma Ltd?

According to Nasus Pharma Ltd's FY2025 earnings report, its operating profit was -4.90M, with a year-on-year change of -354.92.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.